MGC BioPQQ
MGC BioPQQ, a subsidiary of the MGC Group, is a leading player in the biotechnology industry, headquartered in Japan. Established in 2015, the company has rapidly gained recognition for its innovative approach to health and wellness, particularly in the development of bioactive compounds. Specialising in the production of Pyrroloquinoline Quinone (PQQ), MGC BioPQQ offers unique products that support cellular energy and overall vitality. Their commitment to quality and scientific research has positioned them as a trusted name in the market, catering to both domestic and international clients. With a focus on sustainability and cutting-edge technology, MGC BioPQQ continues to make significant strides in the health supplement sector, contributing to advancements in nutritional science and enhancing consumer well-being.
DitchCarbon Score
How does MGC BioPQQ's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MGC BioPQQ's score of 10 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MGC BioPQQ's reported carbon emissions
In 2022, MGC BioPQQ reported total carbon emissions of approximately 11,434,000,000 kg CO2e, with emissions distributed across various scopes: 744,000,000 kg CO2e (Scope 1), 584,000,000 kg CO2e (Scope 2), and 10,434,000,000 kg CO2e (Scope 3). The company has set ambitious long-term climate commitments, aiming for a zero-carbon society by 2050, with specific targets for both Scope 1 and Scope 2 emissions. These targets were established in 2023 and reflect MGC BioPQQ's commitment to promoting energy transition. The emissions data for 2021 showed a total of approximately 11,358,000,000 kg CO2e, with Scope 1 emissions at 770,000,000 kg CO2e and Scope 2 emissions at 717,000,000 kg CO2e. In 2020, the total emissions were about 9,172,000,000 kg CO2e, with Scope 1 at 653,000,000 kg CO2e and Scope 2 at 709,000,000 kg CO2e. MGC BioPQQ's emissions data is not cascaded from a parent company, ensuring that their reported figures are independently sourced. The company is actively working towards its climate goals, reflecting a strong commitment to sustainability and carbon reduction in alignment with global climate initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 749,010,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 222,812,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 7,134,439,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MGC BioPQQ is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
